13 lines
1.7 KiB
Plaintext
13 lines
1.7 KiB
Plaintext
|
"","","资规模","金额","金额","阶段性成果","到目标","水平","应用前景"
|
|||
|
"1","冻干人用狂犬病疫苗(Vero细胞)","10000.00","1599.09","11578.76","注册申请中","获得生产批件","国内领先","用于预防狂犬病"
|
|||
|
"2","四价流感病毒裂解疫苗(儿童)","33000.00","410.69","1481.50","III期临床试验前期准备中","获得生产批件","国内领先","用于预防流行性感冒"
|
|||
|
"3","23价肺炎球菌多糖疫苗/13价肺炎球菌多糖结合疫苗","22980.00","123.49","631.25","临床前研究","获得生产批件","国内领先","用于预防肺炎"
|
|||
|
"4","冻干水痘减毒活疫苗","31975.00","225.03","946.69","临床前研究","获得生产批件","国内领先","用于预防水痘"
|
|||
|
"5","四价流感病毒裂解疫苗(高剂量)","11745.00","110.64","1961.90","临床前研究","获得生产批件","国内领先","用于预防流行性感冒"
|
|||
|
"6","重组带状疱疹疫苗","31975.00","168.99","429.68","临床前研究","获得生产批件","国内领先","用于预防带状疱疹"
|
|||
|
"7","冻干人用狂犬病疫苗(MRC-5细胞)","27915.00","33.77","200.46","临床前研究","获得生产批件","国内领先","用于预防狂犬病"
|
|||
|
"8","多价手足口病疫苗","29910.00","33.77","199.29","临床前研究","获得生产批件","国内领先","用于预防手足口病"
|
|||
|
"9","注射用重组人IL12/15-PDL1单纯疱疹I型溶瘤病毒注射液","38910.00","33.49","350.71","临床前研究","获得生产批件","新药","实体瘤治疗"
|
|||
|
"10","在中国3至8岁儿童中四价流感病毒裂解疫苗2针次免疫程序的探索研究","300.00","54.38","225.80","临床研究完成","获得注册批件","国内领先","预防流行性感冒"
|
|||
|
"合计","/","238710.00","2793.34","18006.04","/","/","/","/"
|